Randall Wong

Company: 4D Molecular Therapeutics

Job title: Executive Director - Medical Affairs

Seminars:

4D-150 Intravitreal Gene Therapy: Phase II & Phase III Data 12:00 pm

Understanding the advantages of intravitreal injection platform to appreciate superior delivery method over competing approaches Examining the unbelievably earth-shatteringly safe Phase III wet AMD trial data to recognize breakthrough safety profiles in gene therapy Exploring the scientific evidence behind customized capsids to understand why 4DMT has solved safety challenges where nobody else hasRead more

day: Conference Day One